Detalles de la búsqueda
1.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816326
2.
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.
BMC Bioinformatics
; 18(1): 516, 2017 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29169317
3.
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
Hematol Oncol
; 32(3): 133-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24254547
4.
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.
Br J Haematol
; 181(5): 693-695, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28369711
5.
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma.
Ann Hematol
; 92(11): 1503-11, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23737092
6.
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.
Exp Hematol
; 34(12): 1680-6, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17157165
7.
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network.
Leuk Lymphoma
; 57(2): 400-410, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115509
8.
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
J Mol Diagn
; 17(6): 652-60, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26319783
9.
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Clin Cancer Res
; 20(24): 6398-405, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316810
10.
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma.
Ther Adv Hematol
; 4(3): 189-98, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23730496
11.
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.
Mech Ageing Dev
; 133(7): 479-88, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22687638
12.
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.
Blood
; 105(12): 4784-91, 2005 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15731178
Resultados
1 -
12
de 12
1
Próxima >
>>